Invention Grant
- Patent Title: Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2
-
Application No.: US16116271Application Date: 2018-08-29
-
Publication No.: US10717775B2Publication Date: 2020-07-21
- Inventor: Mark Marchionni
- Applicant: Acorda Therapeutics, Inc.
- Applicant Address: US NY Ardsley
- Assignee: Acorda Therapeutics, Inc.
- Current Assignee: Acorda Therapeutics, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K49/00 ; A61K38/18 ; C07K14/475 ; C07K14/48 ; C07K14/00 ; A61K35/34 ; A61K38/16 ; A61K45/00 ; A61K38/17 ; A61K47/42 ; C07K14/485 ; A61P9/06 ; A61P9/00 ; A61P9/04 ; C07K14/47 ; C07K14/71 ; A61P9/10 ; G01N33/50 ; G01N33/68 ; A61K39/00
Abstract:
The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.
Public/Granted literature
Information query
IPC分类:
